Is too much money being invested in oncology?
Oncology startups are raking in lion's share of early-stage capital and recent M&A's have also been heavily weighted toward oncology. Is too much capital going to overcome cancer?
Oncology startups are raking in lion's share of early-stage capital and recent M&A's have also been heavily weighted toward oncology. Is too much capital going to overcome cancer?